ClariVein®消融术后压迫治疗:COMMOCA随机对照试验
本研究为随机对照试验,旨在评估机械化学消融(MOCA)治疗静脉曲张主干功能不全后压迫治疗的作用。患者随机分为压迫组(A组)和无压迫组(B组),主要目标是评估术后前10天使用视觉模拟量表测量的疼痛评分。次要目标包括压迫依从性、生活质量、临床有效性、瘀斑和静脉炎发生率、恢复正常活动时间、患者满意度及6个月闭塞率。
要点
- 评估MOCA术后压迫治疗对疼痛评分的影响。
- 次要结局包括依从性、生活质量、并发症及6个月闭塞率。
- 研究结果可能为MOCA术后压迫治疗提供依据。
核心结论
- 本试验旨在明确MOCA术后压迫治疗的作用。
研究设计与样本
- 随机对照试验,患者随机分为压迫组(A组)和无压迫组(B组)。
- 伦理批准来自Singhealth Centralised Institutional Review Board(CIRB Ref: 2017/2710)。
- 试验注册于ClinicalTrials.gov,NCT03685838,注册日期2018年9月26日。
关键数值与推荐
- 主要目标:术后前10天使用视觉模拟量表评估疼痛评分。
- 次要目标:压迫依从性、生活质量评分、临床有效性、瘀斑和静脉炎发生率、恢复正常活动时间、患者满意度、6个月闭塞率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovenous treatment of varicose veins has increased in popularity over the last decade. There remains, however, a degree of uncertainty regarding the role of compression bandaging or hosiery following this intervention. The National Institute for Clinical Excellence Guideline Development Group has advocated further research to evaluate the clinical and cost-effectiveness of this post-procedure intervention. In addition to this, the duration of compression bandaging also warrants clarification. METHODS: Ethical approval for the study was obtained from the Singhealth Centralised Institutional Review Board (CIRB Ref: 2017/2710). Consent to enter the study will be sought from each participant only after a full explanation has been given, an information leaflet offered and time allowed for consideration. Signed participant consent will be obtained. Patients will be randomised to either compression (group A) or no compression (group B). The primary aim of the study is to assess the patient's pain scores for the first 10 days post procedure using a visual analogue scale. Secondary aims include an assessment of patient compliance with compression, quality of life scores, clinical effectiveness, rates of bruising and phlebitis, time taken to return to normal activities, patient satisfaction and occlusion rate at 6 months. DISCUSSION: The purpose of this study is to examine the effect of compression therapy in patients having mechano-chemical ablation (MOCA) therapy for truncal incompetence of their varicose veins using the ClariVein® device. This study may provide clarification on the role of compression therapy in patients undergoing MOCA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03685838. Registered on 26 September 2018.
引用
- Joyce DP, Walsh SR, Yap CJQ, et al. Compression therapy following ClariVein® ablation therapy: a randomised controlled trial of COMpression Therapy Following MechanO-Chemical Ablation (COMMOCA). Trials. 2019. PMID: 31806052. doi:10.1186/s13063-019-3787-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。